Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 5:08 AM ET

Life Sciences Tools and Services

Company Overview of Celerion Inc.

Company Overview

Celerion Inc. provides early clinical research services for pharmaceutical and biotechnology companies in the United States and internationally. The company focuses on delivering applied translational medicine to support early drug development decisions. Its services include global clinical research (Phase I and II, and NDA-enabling clinical pharmacology study conduct); clinical pharmacology sciences (modeling and simulation, study design and protocol development, clinical data sciences, biostatistics, pharmacokinetics/pharmacodynamics (PK/PD), and medical writing and reporting); global bioanalytical services (discovery to late stage services with capabilities in small and large drug, and me...

621 Rose Street

Lincoln, NE 68502-2040

United States

Founded in 2010





Key Executives for Celerion Inc.

Chief Executive officer and President
Age: 62
Chief Financial Officer
Chief Cardiologist and Global Medical Director of Cardiac Safety Services
Senior Vice President of Global Clinical Development
Vice President of Global Business Development
Compensation as of Fiscal Year 2015.

Celerion Inc. Key Developments

Celerion Inc. Presents at BIO-Europe 2015, Nov-02-2015

Celerion Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Celerion Expands Ophthalmological Capabilities to Patient Populations in Collaboration with Queen's University, Belfast

Celerion, announced the expansion of ophthalmological services in the Belfast, Northern Ireland UK facility, by building on the successful relationship with Queen's University in Belfast. Celerion will expand its collaboration with Queen's University for access to patient populations, specialized procedures and their scientific expertise in this area. This new focus will enable Celerion to apply expertise acquired from several years of performing precise ophthalmologic measurements as part of assessing the safety of new drug candidates. By moving beyond clinical safety assessment, Celerion scientists and colleagues at The Centre for Experimental Medicine at Queen's University can perform assessments of drug effect in a controlled research environment. The focus will be on patients with eye diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma, and retinal vein occlusions.

Celerion Appoints Robert Lester as Chief Cardiologist, Global Medical Director of Cardiac Safety Services

Celerion announced the appointment of Robert Lester MD FACC, as Chief Cardiologist, Global Medical Director of Cardiac Safety Services. Dr. Lester will develop and lead Celerion's strategic vision in Cardiac Safety Services. He will be based in the facility in Phoenix, Arizona. Dr. Lester comes to Celerion with over 25 years experience in clinical medicine and academia, as well as over 13 years experience as a Director and Senior Cardiologist at several Contract Research Organizations (CROs) and ECG Core labs. Dr. Lester will utilize his extensive experience and expertise in the area of cardiac safety, to provide advice and lead client programs. He will also be a driving force for Celerion's innovative Highly Automated ECG Core Lab that enables clients to expedite ECG review, thereby significantly reducing the time and cost for cardiac safety studies over traditional approaches.

Similar Private Companies By Industry

Company Name Region
Latitude Pharmaceuticals Inc. United States
Goodwin Biotechnology, Inc. United States
Columbus Regional Research Institute LLC United States
Eksigent Technologies, Inc. United States
Poly-Med, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celerion Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at